Momenta Pharmaceuticals to Webcast Presentation at the 2013 Deutsche Bank BioFEST Conference
November 25, 2013 16:05 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Nov. 25, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences
November 06, 2013 16:05 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Nov. 6, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Reports Third Quarter 2013 Financial Results
November 05, 2013 08:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Nov. 5, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Announces Date of Third Quarter 2013 Financial Results Conference Call and Webcast
October 15, 2013 08:30 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Oct. 15, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
Momenta Pharmaceuticals to Webcast Presentations at Three Upcoming Investor Conferences
September 04, 2013 09:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Sept. 4, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals to Present at Canaccord Genuity 33rd Annual Growth Conference
August 06, 2013 16:05 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Aug. 6, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Reports Second Quarter 2013 Financial Results
August 01, 2013 08:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Aug. 1, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs,...
Momenta Pharmaceuticals Announces Potential for 2014 Market Entry of Generic Copaxone(R)
July 26, 2013 13:18 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., July 26, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today announced that the United States Court of Appeals for the Federal Circuit (the "Federal Circuit")...
Momenta Pharmaceuticals Announces Date of Second Quarter 2013 Financial Results Conference Call and Webcast
July 16, 2013 09:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., July 16, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
Momenta Pharmaceuticals Announces Issuance of U.S. Patent for Sialylation Technology
June 25, 2013 08:30 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., June 25, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...